AU2897195A - Assay for increased invasiveness of epithelial cells - Google Patents

Assay for increased invasiveness of epithelial cells

Info

Publication number
AU2897195A
AU2897195A AU28971/95A AU2897195A AU2897195A AU 2897195 A AU2897195 A AU 2897195A AU 28971/95 A AU28971/95 A AU 28971/95A AU 2897195 A AU2897195 A AU 2897195A AU 2897195 A AU2897195 A AU 2897195A
Authority
AU
Australia
Prior art keywords
assay
epithelial cells
increased invasiveness
invasiveness
increased
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28971/95A
Inventor
Frans M. J Debruyne
Jack A. Schalken
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FRANS M J DEBRUYNE
Original Assignee
FRANS M J DEBRUYNE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FRANS M J DEBRUYNE filed Critical FRANS M J DEBRUYNE
Publication of AU2897195A publication Critical patent/AU2897195A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
AU28971/95A 1994-07-08 1995-07-10 Assay for increased invasiveness of epithelial cells Abandoned AU2897195A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US272213 1988-11-14
US27221394A 1994-07-08 1994-07-08
PCT/IB1995/000577 WO1996002002A1 (en) 1994-07-08 1995-07-10 Assay for increased invasiveness of epithelial cells

Publications (1)

Publication Number Publication Date
AU2897195A true AU2897195A (en) 1996-02-09

Family

ID=23038873

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28971/95A Abandoned AU2897195A (en) 1994-07-08 1995-07-10 Assay for increased invasiveness of epithelial cells

Country Status (2)

Country Link
AU (1) AU2897195A (en)
WO (1) WO1996002002A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861248A (en) * 1996-03-29 1999-01-19 Urocor, Inc. Biomarkers for detection of prostate cancer
WO2000060119A2 (en) * 1999-04-01 2000-10-12 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for detecting cancer cells
ES2161655B1 (en) 1999-07-01 2002-06-01 Consejo Superior Investigacion PROCEDURE TO DETERMINE THE INVASIVE AND METASTASSIC CAPACITY OF AN EPITELIAL TUMOR THROUGH THE USE OF SNAIL.
AU5068800A (en) * 1999-12-23 2001-07-09 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Novel cDNAs encoding catenin-binding proteins with function in signalling and/orgene regulation
AU2001269106A1 (en) 2000-07-12 2002-01-21 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Novel alpha expressed in heart and testis
US7229778B2 (en) 2004-02-26 2007-06-12 The Procter & Gamble Company Methods for determining the relative benefits and/or evaluating quantitative changes of products on epithelial tissue

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4110405A1 (en) * 1991-03-28 1992-10-01 Birchmeier Walter Prof Dr METHOD FOR DETECTING DIFFERENTIATION AND INVASIVITY OF CARCINOMA CELLS
JP3504676B2 (en) * 1992-07-10 2004-03-08 エーザイ株式会社 Monoclonal antibody against α-catenin
AU5669494A (en) * 1992-11-17 1994-06-08 Yale University Human homolog of the e-cadherin gene and methods based thereon

Also Published As

Publication number Publication date
WO1996002002A1 (en) 1996-01-25

Similar Documents

Publication Publication Date Title
AU6327798A (en) Multiple assays of cell specimens
EP0742287B8 (en) Modified nucleic acid probes
AU5705898A (en) Mammalian cell surface antigens; related reagents
AU4917096A (en) Multifunctional enzyme
AU5871396A (en) Enzyme linked oligonucleotide assays (elonas)
AU8121098A (en) Cell activation process and reagents therefor
AU6869198A (en) Universal stem cells
AU2597995A (en) Reagents and methods for the rapid and quantitative assay of pharmacological agents
AU1141597A (en) Electronically-solid-phase assay biomolecules
AU5644396A (en) Novel heterocyclic chemistry
AU1115897A (en) Nima interacting proteins
AU3574997A (en) Mammalian chemokine reagents
AU7410898A (en) Assay for detecting apoptotic cells
AU5494396A (en) Universal chuck
AU3334595A (en) Assay for the detection of proteases
AU5856696A (en) Novel single-component solid oxide bodies
AU2315195A (en) Nucleic acid mutation assays
AU5002096A (en) Alkaline lipolytic enzyme
AU2016100A (en) New assay
AU2897195A (en) Assay for increased invasiveness of epithelial cells
AUPN366895A0 (en) Detection of small analytes
AU2824197A (en) Cell wall assay
AU5905094A (en) Nucleic acid assay procedure
AU3586595A (en) Preparation of immortalized cells
AU6376698A (en) Improved nucleic acid assays